LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong · Delayed Price · Currency is HKD 10.87
-0.42 (-3.72%)
Sep 11, 2026, 11:46 AM HKT
HKG:2291 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,915 | 5,576 | 6,040 | 9,432 | 9,934 | - | |
Market Cap Growth | -49.24% | -7.69% | -35.96% | -5.06% | - | - |
Enterprise Value | 2,429 | 4,069 | 4,629 | 8,121 | 9,078 | - |
Last Close Price | 11.29 | 15.27 | 16.00 | 24.14 | 25.42 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.64 | 20.90 | 23.12 | 56.56 | - | - |
Forward PE | 6.71 | 11.88 | - | - | - | - |
PS Ratio | 6.67 | 9.49 | 12.04 | 26.21 | 35.48 | - |
PB Ratio | 1.69 | 2.46 | 2.84 | 4.44 | 5.04 | - |
P/TBV Ratio | 1.95 | 2.85 | 3.34 | 4.75 | 5.37 | - |
P/FCF Ratio | - | 34.64 | 41.42 | 128.26 | 168.18 | - |
P/OCF Ratio | - | 22.66 | 25.51 | 52.12 | 134.10 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.14 | 6.93 | 9.22 | 22.57 | 32.42 | - |
EV/EBITDA Ratio | 7.85 | 12.50 | 16.59 | 46.39 | 68.06 | - |
EV/EBIT Ratio | 9.13 | 14.24 | 17.02 | 48.22 | 75.78 | - |
EV/FCF Ratio | - | 25.28 | 31.74 | 110.44 | 153.69 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0 | 0.00 | 0 | 0.00 | 0.02 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.06 |
Debt / FCF Ratio | - | 0.01 | 0.01 | 0.01 | 0.06 | 0.08 |
Net Debt / Equity Ratio | -0.64 | -0.58 | -0.62 | -0.66 | -0.69 | -1.84 |
Net Debt / EBITDA Ratio | -4.80 | -4.02 | -4.70 | -7.97 | -10.16 | -6.81 |
Net Debt / FCF Ratio | - | -8.14 | -8.99 | -18.97 | -22.95 | -8.54 |
Asset Turnover | 0.23 | 0.25 | 0.23 | 0.17 | 0.17 | 0.31 |
Inventory Turnover | 0.95 | 0.82 | 0.61 | 0.50 | 0.45 | 0.75 |
Quick Ratio | 5.98 | 20.97 | 15.47 | 21.97 | 19.52 | 1.01 |
Current Ratio | 6.54 | 23.54 | 16.79 | 23.90 | 20.92 | 1.09 |
Return on Equity (ROE) | 10.27% | 11.88% | 12.52% | 8.25% | -1.86% | 18.38% |
Return on Assets (ROA) | 6.37% | 7.68% | 7.85% | 5.03% | 4.52% | 8.24% |
Return on Invested Capital (ROIC) | 27.84% | 27.41% | 30.77% | 22.18% | 94.98% | - |
Return on Capital Employed (ROCE) | 11.50% | 12.60% | 12.80% | 7.90% | 6.10% | 24.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.02% | 4.78% | 4.33% | 1.77% | -0.22% | - |
FCF Yield | - | 2.89% | 2.41% | 0.78% | 0.60% | - |
Dividend Yield | 4.39% | 3.64% | 4.12% | 2.60% | - | - |
Payout Ratio | - | 89.68% | 79.32% | - | - | 545.17% |
Buyback Yield / Dilution | 0.00% | - | - | -5.86% | -7.79% | -9.63% |
Total Shareholder Return | 4.40% | 3.64% | 4.12% | -3.26% | -7.79% | -9.63% |